Your browser is no longer supported. Please, upgrade your browser.
Settings
EARS Auris Medical Holding Ltd. daily Stock Chart
EARS [NASD]
Auris Medical Holding Ltd.
Index- P/E- EPS (ttm)-21.92 Insider Own16.57% Shs Outstand1.89M Perf Week0.37%
Market Cap5.12M Forward P/E- EPS next Y-4.99 Insider Trans0.00% Shs Float1.51M Perf Month-2.52%
Income-11.80M PEG- EPS next Q-1.64 Inst Own23.00% Short Float11.47% Perf Quarter1.88%
Sales- P/S- EPS this Y87.00% Inst Trans- Short Ratio0.91 Perf Half Y-61.93%
Book/sh2.44 P/B1.11 EPS next Y- ROA-111.70% Target Price14.50 Perf Year-49.25%
Cash/sh2.91 P/C0.93 EPS next 5Y- ROE- 52W Range2.41 - 39.40 Perf YTD-70.29%
Dividend- P/FCF- EPS past 5Y34.10% ROI- 52W High-93.12% Beta-0.03
Dividend %- Quick Ratio1.30 Sales past 5Y- Gross Margin- 52W Low12.45% ATR0.16
Employees11 Current Ratio1.30 Sales Q/Q- Oper. Margin- RSI (14)47.89 Volatility7.47% 5.98%
OptionableNo Debt/Eq0.41 EPS Q/Q87.60% Profit Margin- Rel Volume0.30 Prev Close2.72
ShortableYes LT Debt/Eq0.00 EarningsAug 28 BMO Payout- Avg Volume189.81K Price2.71
Recom- SMA20-1.23% SMA50-0.83% SMA200-57.86% Volume56,819 Change-0.37%
Oct-08-18Initiated Euro Pacific Capital Buy $2.50
Apr-13-17Initiated ROTH Capital Buy $4.50
Aug-19-16Reiterated Needham Buy $11 → $5
Sep-09-14Initiated Needham Buy $11
Aug-23-19 10:21AM  New Strong Sell Stocks for August 23rd Zacks
Aug-22-19 10:06AM  New Strong Sell Stocks for August 22nd Zacks
Aug-15-19 07:00AM  Auris Medical Provides Business Update and Reports First Half 2019 Financial Results GlobeNewswire
Jul-30-19 08:30AM  Auris Medical Announces Randomization of First Patient in AM-125 Phase 2 Trial in Acute Vertigo GlobeNewswire
Jul-03-19 09:00AM  Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial of AM-201 in Antipsychotic-Induced Weight Gain GlobeNewswire
Jun-13-19 09:50AM  Savara Plunges on Failure of Late-Stage Study on Molgradex Zacks
May-23-19 09:00AM  Auris Medical Holding Ltd Provides Corporate Update GlobeNewswire
May-20-19 08:45AM  Auris Medical Holding Ltd Regains Compliance with Nasdaq Minimum Bid Price Rule GlobeNewswire -7.37%
May-17-19 04:55PM  Penny Stocks to Buy Using Technical Analysis for May 2019 Investopedia
May-15-19 04:15PM  Auris Medical Announces Closing of Public Offering of Common Shares GlobeNewswire -5.43%
09:00AM  Auris Medical Announces Closing of Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHD GlobeNewswire
May-13-19 08:30AM  Auris Medical Holding Ltd.: GlobeNewswire -19.63%
May-07-19 09:00AM  Auris Medical Reaches Midpoint for Enrollment in AM-201 Phase 1b Proof-of-Concept Study in Antipsychotic-Induced Weight Gain GlobeNewswire -6.14%
Apr-30-19 08:30AM  Auris Medical Announces Reverse Stock Split GlobeNewswire -9.00%
Apr-25-19 09:00AM  Auris Medical Provides Update on Tinnitus Drug Development Strategy GlobeNewswire
Apr-18-19 12:11PM  Buyer's Remorse? OTC Stock Zoom Technologies Zooms Higher Amid Potential Buyer Confusion Benzinga
Apr-15-19 09:00AM  Auris Medical Receives Positive Nasdaq Listing Determination GlobeNewswire
Mar-29-19 09:01AM  Auris Medical Announces Randomization of First Dose Cohort in AM-201 Phase 1b Proof-of-Concept Study GlobeNewswire
Mar-14-19 09:48PM  Auris Medical Announces 20-F Filing GlobeNewswire
02:30PM  These Four Healthcare Stocks Could Test March Highs ACCESSWIRE
07:58AM  Auris: 4Q Earnings Snapshot Associated Press
07:00AM  Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Mar-11-19 08:51AM  Auris Medical Announces Publication of AM-111 Phase 3 Results in Peer-Reviewed Scientific Journal GlobeNewswire +5.25%
Mar-07-19 08:01AM  Auris Medical to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on Thursday, March 14, 2019 GlobeNewswire +6.56%
Feb-13-19 10:42AM  Case of Mistaken Identity Sends Auris Medical Shares Soaring 30% Bloomberg +9.17%
Feb-08-19 05:00PM  Auris Medical Announces Receipt of Nasdaq Notice GlobeNewswire
Feb-01-19 07:31AM  Auris Medical Announces Full Repayment of Hercules Loan Facility GlobeNewswire +5.33%
Jan-29-19 07:31AM  Auris Medical to Redomicile Holding Company from Switzerland to Bermuda GlobeNewswire
Jan-23-19 09:45AM  4 Healthcare Stocks Making Moves On Wednesday (1/23/19) ACCESSWIRE +13.07%
08:31AM  Auris Medical Announces Publication of New Data Highlighting the Role of Betahistine in Promoting the Restoration of Forgotten Memories in Mice and Healthy Volunteers GlobeNewswire
Jan-15-19 08:31AM  Auris Medical Provides Update on Intranasal Betahistine Programs GlobeNewswire +7.94%
Dec-06-18 09:15AM  New Healthcare Trends Pushing Stocks Higher On Thursday ACCESSWIRE
07:31AM  Auris Medical Announces Acquisition of Orphan Drug Designation and Secures Rights to In-License Additional Patents Related to Betahistine GlobeNewswire
Nov-26-18 09:00AM  Biotech and Cannabis Stocks to Watch ACCESSWIRE
Nov-23-18 07:40AM  Detailed Research: Economic Perspectives on Wingstop, Marlin Business Services, Aware, Zynerba Pharmaceuticals, Auris Medical Holding AG, and Gulf Island Fabrication What Drives Growth in Today's Competitive Landscape GlobeNewswire +15.54%
Nov-21-18 07:00AM  Today's Research Reports on Trending Tickers: Auris Medical and Bioblast Pharma ACCESSWIRE -11.73%
Nov-20-18 09:20AM  Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program in Olanzapine-Induced Weight Gain GlobeNewswire +35.81%
Nov-15-18 07:22AM  Auris: 3Q Earnings Snapshot Associated Press
06:45AM  Auris Medical Reports Third Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Nov-08-18 07:00AM  Auris Medical to Report Third Quarter 2018 Financial Results and Provide Business Update on Thursday, November 15, 2018 GlobeNewswire
Nov-02-18 08:00AM  Today's Research Reports on Trending Tickers: Loxo Oncology and Auris Medical Holding ACCESSWIRE -19.98%
Nov-01-18 12:00PM  Edison issues initiation on Auris Medical Holding (EARS) GlobeNewswire +49.14%
Oct-17-18 06:45AM  Auris Medical Announces Positive Results From Second Phase 1 Clinical Trial With Intranasal Betahistine GlobeNewswire -20.95%
Oct-16-18 08:00AM  Todays Research Reports on Stocks to Watch: Auris Medical Holding and Agile Therapeutics ACCESSWIRE +7.25%
Oct-15-18 04:32PM  Why Auris Medical Stock Is Soaring Today InvestorPlace +40.82%
Oct-12-18 07:30AM  Auris Medical to provide update on intranasal betahistine program on Wednesday, October 17, 2018 GlobeNewswire +44.12%
Oct-09-18 08:10AM  Auris Medical Shares Gain on Initiated Coverage, Analysts Review and Target ACCESSWIRE -6.41%
08:00AM  Todays Research Reports on Stocks to Watch: Auris Medical Holding and Menlo Therapeutics ACCESSWIRE
Aug-30-18 08:16AM  Auris Medical Receives FDA Guidance at Type C Meeting for AM-111 in the Treatment of Sudden Sensorineural Hearing Loss GlobeNewswire +17.79%
Aug-15-18 06:59AM  Auris: 2Q Earnings Snapshot Associated Press -12.98%
06:45AM  Auris Medical Reports Second Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Aug-09-18 08:01AM  Auris Medical to Report Second Quarter 2018 Financial Results and Provide Business and Update on Wednesday, August 15, 2018 GlobeNewswire
Jul-13-18 07:40AM  Complimentary Technical Snapshots on OHR Pharma and Three More Biotech Stocks ACCESSWIRE -47.14%
Jul-12-18 08:00PM  Auris Medical Prices $7 Million Public Offering GlobeNewswire -21.13%
Jul-03-18 08:01AM  Auris Medical Announces Publication Confirming Dose-Dependent Effects of Betahistine and Relationship to Bioavailability in Cat Model of Acute Vertigo GlobeNewswire
Jun-13-18 07:05AM  Free Technical Reports on Arrowhead Pharma and Three Additional Biotech Equities ACCESSWIRE
Jun-04-18 12:34PM  What Are The Drivers Of Auris Medical Holding AGs (NASDAQ:EARS) Risks? Simply Wall St.
May-30-18 07:45AM  Auris Medical to Host Key Opinion Leader Call Focused on AM-201 Program for Treating Major Side Effects of Antipsychotics on June 11, 2018 GlobeNewswire
May-22-18 10:13PM  Edited Transcript of EARS earnings conference call or presentation 15-May-18 12:00pm GMT Thomson Reuters StreetEvents
May-15-18 06:56AM  Auris: 1Q Earnings Snapshot Associated Press -6.47%
06:45AM  Auris Medical Provides Business and Strategy Update and Reports First Quarter 2018 Financial Results GlobeNewswire
May-14-18 07:30AM  Auris Medical to Report First Quarter 2018 Financial Results and Provide Business and Strategy Update on Tuesday, May 15, 2018 GlobeNewswire
May-08-18 07:30AM  Wired News Auris Medical Reported Publication Related to AM-111 in Peer-Reviewed Scientific Journal Hearing Research ACCESSWIRE
May-07-18 09:05AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +9.39%
07:30AM  Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111 GlobeNewswire
May-04-18 06:45AM  Auris Medical Announces Publication Related to AM-111 in Peer-Reviewed Scientific Journal GlobeNewswire +29.29%
Apr-09-18 06:45AM  Auris Medical Announces Early Repayment of Part of its Loan Facility GlobeNewswire
Apr-02-18 07:30AM  Blog Exposure - Actinium Announces Collaboration with Astellas Pharma ACCESSWIRE
Mar-29-18 07:01AM  Auris Regains Compliance with Nasdaq's Minimum Bid Price Requirement GlobeNewswire -6.43%
Mar-22-18 09:56AM  Auris reports 4Q loss Associated Press +15.89%
09:05AM  Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
Mar-14-18 08:53AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga -34.52%
Mar-13-18 04:15PM  Auris Medical Provides Business Update GlobeNewswire -8.13%
Feb-27-18 06:15PM  What Are The Drivers Of Auris Medical Holding AGs (NASDAQ:EARS) Risks? Simply Wall St. -5.77%
Feb-26-18 08:31AM  Auris Medical to Host Key Opinion Leader Call Focused on Keyzilen® Tinnitus Program on March 5, 2018 GlobeNewswire
Feb-09-18 08:00AM  Auris Medical Announces Extraordinary General Meeting of Shareholders GlobeNewswire -14.42%
Feb-07-18 09:11AM  Auris Medical Reports New Data Highlighting Superior Bioavailability of AM-125 Compared to Oral Betahistine GlobeNewswire
Jan-29-18 04:31PM  Auris Medical Announces Pricing of $5.5 Million Registered Direct Offering GlobeNewswire
Jan-04-18 08:30AM  Auris Medical Provides Update on AM-111 Development Program GlobeNewswire -11.52%
Dec-28-17 08:30AM  Auris Medical News Release - Auris Medical to Provide Update on Its AM-111 Hearing Loss Program on Thursday, January 4, 2018 GlobeNewswire +33.12%
Dec-08-17 03:33PM  Who Really Owns Auris Medical Holding AG (EARS)? Simply Wall St. +5.72%
Nov-29-17 08:58PM  Edited Transcript of EARS earnings conference call or presentation 28-Nov-17 1:00pm GMT Thomson Reuters StreetEvents +9.40%
07:00AM  [$$] Decibel Therapeutics, Regeneron Strike Deal for Hearing Treatments The Wall Street Journal
Nov-28-17 11:19AM  Auris Medical shares plunge as deafness drug trial scrapped Reuters -48.17%
10:22AM  Heres What Triggered Auris Medical Holding AG (EARS) Selloff SmarterAnalyst
07:15AM  Auris Medical Holding AG to Host Earnings Call ACCESSWIRE
06:50AM  Auris reports 3Q loss Associated Press
06:45AM  Auris Medical to abandon hearing-loss drug trial Reuters
06:40AM  Auris Medical Reports Third Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
06:40AM  Auris Medical Reports Top-Line Results from Phase 3 Trial of AM-111 in Sudden Deafness GlobeNewswire
Nov-21-17 08:01AM  Auris Medical News Release GlobeNewswire
Nov-09-17 08:05AM  Auris Medical: Clinical Updates and Potential Catalysts ACCESSWIRE
Nov-08-17 11:39AM  What You Must Know About Auris Medical Holding AGs (EARS) Financial Strength Simply Wall St.
Oct-16-17 12:55AM  Edited Transcript of EARS earnings conference call or presentation 14-Mar-16 12:00pm GMT Thomson Reuters StreetEvents
Oct-13-17 07:10AM  Corporate News Blog - Auris Medical Executes Two Share Purchase Agreements with Lincoln Park Capital Fund ACCESSWIRE
Oct-11-17 06:47AM  Auris Medical Announces Share Purchase Agreements with Lincoln Park Capital Fund, LLC GlobeNewswire
Sep-28-17 08:31AM  Auris Medical Announces Transfer to Nasdaq Capital Market GlobeNewswire +9.50%
Sep-26-17 08:31AM  Auris Medical Provides Board of Directors Update GlobeNewswire -7.59%
Sep-22-17 08:01AM  Auris Medical Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Post-Acute Tinnitus GlobeNewswire +14.77%
Sep-20-17 08:01AM  Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27 GlobeNewswire
Auris Medical Holding Ltd., a development-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear and vestibular disorders. The company's Phase 3 programs under the development include Keyzilen (AM-101) for the treatment of acute inner ear tinnitus; and Sonsuvi (AM-111) for the treatment of acute inner ear hearing loss. It is also developing AM-125 for the intranasal treatment of vertigo; and intranasal betahistine for the prevention of weight gain and drowsiness, which are side effects of various antipsychotic drugs. The company has a collaboration and license agreement with Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, as well as drug delivery devices and formulations for local administration of therapeutic substances to the inner ear for the treatment of ear disorders. Auris Medical Holding Ltd. was founded in 1998 and is headquartered in Zug, Switzerland.